Influence of dynamic obstruction and hypertrophy location on diastolic function in hypertrophic cardiomyopathy

Gustavo Avegliano1, J Pablo Costabel, Marina Huguet

  • 1aCardiac Imaging Department, Instituto Cardiovascular de Buenos Aires, Buenos Aires, Argentina bCenter for Computational Imaging and Simulation Technologies in Biomedicine, Universitat Pompeu Fabra cCetir Sant Jordi dCentro Cardiovascular Sant Jordi eInstitució Catalana de Recerca i Estudis Avançats, Barcelona, Spain.

Insights

Hypertrophic cardiomyopathy (HCM) subtypes show distinct diastolic dysfunction. Obstructive asymmetric septal HCM has greater impairment than nonobstructive septal and apical forms, impacting clinical outcomes.

Area of Science:

  • Cardiology
  • Echocardiography
  • Cardiovascular Imaging

Background:

  • Hypertrophic cardiomyopathy (HCM) presents significant genetic and phenotypic variability.
  • Obstructive septal forms of HCM are associated with poorer clinical outcomes compared to nonobstructive septal and apical variants.

Purpose of the Study:

  • To investigate differences in left ventricular diastolic function across various HCM subgroups.
  • To evaluate how hypertrophy location and dynamic obstruction influence diastolic dysfunction and clinical status.

Main Methods:

  • Eighty-six patients with HCM were analyzed, categorized into obstructive asymmetric septal (OAS), nonobstructive asymmetric septal (NOAS), and apical (ApHCM) types.
  • Conventional and tissue Doppler echocardiography assessed diastolic function per latest guidelines.
  • Cardiac magnetic resonance quantified left ventricular mass and analyzed morphologic subtypes.

Main Results:

  • Early diastolic annular velocity (e') was significantly lower in OAS (5 cm/s) versus NOAS (7 cm/s) and ApHCM (7.5 cm/s).
  • The E/e' ratio was highest in OAS (14), followed by NOAS (10) and ApHCM (8.5).
  • No significant differences in left ventricular mass or maximal wall thickness were observed between groups.

Conclusions:

  • The location of left ventricular hypertrophy and dynamic obstruction significantly impact diastolic dysfunction severity in HCM.
  • Obstructive asymmetric septal HCM exhibits greater diastolic impairment, while apical involvement shows markedly less dysfunction.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
805
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.9K
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
790
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
753
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
1.8K
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
3.3K